Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Globus Medical Inc (NY: GMED )

85.29 +0.76 (+0.90%)
Official Closing Price Updated: 7:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical Inc

< Previous 1 2 3 4 5 6 7 Next >
What 8 Analyst Ratings Have To Say About Globus Medical
Via Benzinga
Globus Medical (GMED) Q2 2024 Earnings Call Transcript
GMED earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
GMED Stock Earnings: Globus Medical Beats EPS, Beats Revenue for Q2 2024
GMED stock results show that Globus Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Globus Medical Reports Second Quarter 2024 Results
From Globus Medical
Via GlobeNewswire
NYSE:GMED is showing decent growth, but is still valued reasonably.
NYSE:GMED, a growth stock which is not overvalued. 
Via Chartmill
Peering Into Globus Medical's Recent Short Interest
Via Benzinga
Where Globus Medical Stands With Analysts
Via Benzinga
NYSE:GMED is not too expensive for the growth it is showing.
Looking for growth without the hefty price tag? Consider NYSE:GMED. 
Via Chartmill
Deep Dive Into Globus Medical Stock: Analyst Perspectives (7 Ratings)
Via Benzinga
Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System
From Globus Medical
Via GlobeNewswire
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
For those who appreciate growth without the sticker shock, NYSE:GMED is worth considering.
GLOBUS MEDICAL INC - A (NYSE:GMED) is showing decent growth, but is still valued reasonably. 
Via Chartmill
Key Takeaways From Globus Medical Analyst Ratings
Via Benzinga
Looking for growth without the hefty price tag? Consider NYSE:GMED.
Via Chartmill
Staar Surgical Stock Earns RS Rating Upgrade
On Thursday, lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 87 from 77. 
Via Investor's Business Daily
Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
U.S. inflation slowed in May, boosting rate cut prospects. Markets rally ahead of FOMC meeting and assign 70% chance of rate cut in September. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Stryker Stock Sees RS Rating Treks Higher To 71
Stryker stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 63 to 71. 
Via Investor's Business Daily
CrowdStrike To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Don't overlook NYSE:GMED—a stock with solid growth prospects and a reasonable valuation.
Looking for growth without the hefty price tag? Consider GLOBUS MEDICAL INC - A (NYSE:GMED). 
Via Chartmill
This Micron Technology Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Today
Via Benzinga
Globus Medical Shares Race Higher After Better-Than-Expected Q1 Results
Globus Medical reported quarterly earnings of 72 cents per share which beat the analyst consensus estimate of 57 cents by 26.32% and represents a 35.85% increase over earnings from the same period last... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Globus Medical (GMED) Q1 2024 Earnings Call Transcript
GMED earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
GMED Stock Earnings: Globus Medical Beats EPS, Beats Revenue for Q1 2024
GMED stock results show that Globus Medical beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Globus Medical Reports First Quarter 2024 Results
From Globus Medical
Via GlobeNewswire
Investors should take note of NYSE:GMED, a growth stock that remains attractively priced.
For those who appreciate growth without the sticker shock, GLOBUS MEDICAL INC - A (NYSE:GMED) is worth considering. 
Via Chartmill
Globus Medical Schedules First Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
From Six Figures to Seven: 3 Robotics Stocks Set to Make Millionaires
With automated machines set to integrate into everyday functionalities, these are the robotics stocks that could make you rich. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.